← Eichor
Study identifier: NCT07459465 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Postprandial Triglyceride Concentrations Across Menstrual Cycle Phases

Condition: Healthy Adult Females  ·  Sponsor: University of Ottawa

PhaseNA
Planned participants12
Who can joinFemale, 18 Years to 30 Years
Healthy volunteersYes

About this study

The goal of this clinical trial is to investigate the effect of menstrual cycle phases on postprandial triglyceride concentrations in healthy young female adults. The main question it aims to answer is: do postprandial triglyceride concentrations differ between the follicular and luteal phases of the menstrual cycle? Participants will: visit the laboratory for a preliminary screening session to assess eligibility, and undergo two experimental sessions consisting of six hours of seated rest following the consumption of a high-fat meal (one session conducted in the early follicular phase, and one session conducted in the mid-luteal phase of the menstrual cycle).

This description comes directly from the study's public registry record.

Talk to the study team

Pascal Imbeault, PhD  ·  6135625800 ext 7290  ·  imbeault@uottawa.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Behavioural and Metabolic Research Unit, School of Human Kinetics, Faculty of Health Sciences, University of OttawaOttawa, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07459465